A Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Different Doses of Larazotide Acetate for the Treatment of Celiac Disease.

Grants and Contracts Details

StatusFinished
Effective start/end date11/9/11 → 12/31/14

Funding

  • Alba Therapeutics Corp: $28,487.00